Robert Bitterman Buys Shares of PHIO $PHIO
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Robert Bitterman, Chairman, Pres. & CEO at Phio Pharmaceuticals Corp. ($PHIO), bought 10,000 shares at an average price of $0.99, for a total transaction of $9,900. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Phio Pharmaceuticals Corp. Stock Down 12.8%
Shares of Phio Pharmaceuticals Corp. ($PHIO) traded around $0.98 on Tuesday, down 12.8% for the day.
Phio Pharmaceuticals Corp. Earnings
Analysts Set New Price Targets
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Get Phio Pharmaceuticals Corp. alerts
New 13F filings, insider trades, and analyst moves on $PHIO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.